1,239
Views
39
CrossRef citations to date
0
Altmetric
Research Articles

Bacteriophage-antibiotic synergism to control planktonic and biofilm producing clinical isolates of Pseudomonas aeruginosaFootnoteFootnote

, , &
Pages 99-105 | Received 18 Dec 2014, Accepted 21 May 2015, Published online: 17 May 2019

References

  • L.R.PerezA.L.BarthBiofilm production using distinct media and antimicrobial susceptibility profile of Pseudomonas aeruginosaBraz J Infect Dis152011301304
  • D.PiresS.SillankorvaA.FaustinoJ.AzeredoUse of newly isolated phages for control of Pseudomonas aeruginosa PAO1 and ATCC 10145 biofilmsRes Microbiol1622011798806
  • P.LambertMechanisms of antibiotic resistance in Pseudomonas aeruginosaJ R Soc Med920022226
  • A.HassanJ.UsmanF.KaleemM.OmairA.KhalidM.IqbalEvaluation of different detection methods of biofilm formation in the clinical isolatesBraz J Infect Dis1542011305311
  • P.StewartJ.CostertonAntibiotic resistance of bacteria in biofilmsThe Lancet3582001135138
  • J.R.ClarkJ.B.MarchBacteriophages and biotechnology: vaccines, gene therapy and antibacterialsTrends Biotechnol242006212218
  • J.AzeredoI.W.SutherlandThe use of phages for the removal of infectious biofilmsCurr Pharm Biotechnol92008261266
  • B.A.ForbesD.F.SahmA.WeissfeldLaboratory identification of Pseudomonas aeruginosaTwelfth ed.Bailey & Scott’s diagnostic microbiology2007Mosby ELSEVIERPhiladelphia, PA (USA) pp. 340–9
  • Phage Enrichment. Center for Phage Technology Texas A&M University, College Station 2011 [cited 2013 Feb 18]. <http://https://cpt.tamu.edu/wpcontent/uploads/2011/12/Phage-enrichments-07-12-2011.pdf>.
  • Stephenson FH. Calculations for molecular biology and biotechnology, 2nd ed., California: 2010. pp. 83–98.
  • European Committee for Antimicrobial Susceptibility Testing (EUCAST) of the European Society of Clinical Microbiology and Infectious Diseases (ESCMID). Determination of minimum inhibitory concentrations (MICs) of antibacterial agents by broth dilution. Clinical Microbiol Infect 2003; 9(8): 1–7.
  • Clinical and laboratory standards Institute. Performance standard for Antimicrobial susceptibility Testing; twenty fourth informational supplement. CLSI document M100-S24 vol. 31 No.1.Clinical and Laboratory standards Institute, Wayne, PA (USA); 2014.
  • L.CernohorskaM.VotavaAntibiotic synergy against biofilm-forming Pseudomona aeruginosaFolia Microbiol53120085760
  • Science gateway, cell biology protocols, guide for biologist (Internet) Place of publication, Publisher &date of publication unknown Cited 2013 September 17. <http://www.sciencegateway.org/protocols/cellbio>.
  • Virology and bacterial genetic recombination (internet) Place of publication, publisher &date of publication unknown Cited 2013 September 10. <http://www.marietta.edu/~spilatrs/biol202/labexercises/6-Virology.pdf>.
  • Y.ZhangZ.HuCombined treatment of Pseudomonas aeruginosa biofilms with bacteriophages and chlorineBiotechnol Bioeng11012013286295
  • P.KnezevicS.CurcinV.AleksicM.PetrusicL.VlaskiPhage-antibiotic synergism: a possible approach to combatting Pseudomonas aeruginosaRes Microbiol16420125560
  • S.AhiwaleN.TamboliK.ThoratR.KulkarniH.AckermannB.KapadnisIn vitro management of hospital Pseudomonas aeruginosa biofilm using indigenous T7-like lytic phageCurr Microbiol6222011335340
  • E.DeligianniS.PattisonD.BerrarN.G.TernanR.W.HaylockJ.E.MoorePseudomonas aeruginosa Cystic Fibrosis isolates of similar RAPD genotype exhibit diversity in biofilm forming ability invitroBMC Microbiol10201038
  • A.ElsawyH.AlmehdarE.M.RedwanBiofilm formation inhibition of multidrug-resistant of clinical isolates Pseudomonas aeruginosa by lactoferrinAust J Basic Appl Sci712013129132
  • H.CeriM.E.OlsonC.StremickR.R.ReadD.MorckA.BuretThe calgary biofilm device: new technology for rapid determination of antibiotic susceptibilities in bacterial biofilmsJ Clin Microbiol37200117711776
  • Liu C. Biofilm Susceptibility Testing: Can we Eradicate Pseudomonas. In: Pathology. wustl.edu. conference; 10 July 2010.
  • S.SaxenaG.BanerjeeR.GargM.SinghComparative study of biofilm formation in Pseudomonas aeruginosa isolates from patients of lower respiratory tract infectionJ Clin Diagnost Res8520140911
  • K.J.TackL.D.SabathIncreased minimum inhibitory concentrations with anaerobiasis for tobramycin, gentamicin, and amikacin, compared to latamoxef, piperacillin, chloramphenicol, and clindamycinChemotherapy311985204210
  • E.TuomanenR.CozensW.ToschO.ZakA.TomaszThe rate of killing of Escherichia coli by β-lactam antibiotics is strictly proportional to the rate of bacterial growthJ Gen Microbiol132198612971304
  • S.E.HigginK.L.GuentherW.HuffA.M.DonoghueD.J.DonoghueB.M.HargisUse of a specific bacteriophage treatment to reduce Salmonella in poultry productsPoult Sci84200511411145
  • K.MarkoishviliG.TsitlanadzeR.KatsaravaJ.G.MorrisJrA.SulakvelidzeA novel sustained-release matrix based on biodegradable poly(ester amide)s and impregnated with bacteriophages and an antibiotic shows promise in management of infected venous stasis ulcers and other poorly healing woundsInt J Dermatol412002453458
  • A.VieiraY.J.SilvaA.CunhaN.C.M.GomesH.W.AckermannA.AlmeidaPhage therapy to control multidrug-resistant Pseudomonas aeruginosa skin infections: in vitro and ex vivo experimentsEur J Clin Microbiol Infect Dis31201232413249
  • Gurkar A. Potential Application of Phage Therapy Against Pseudomonas aeruginosa Biofilm Infection in Cystic Fibrosis Patients [Bachelor of Science thesis]. Florida International University; 2005.
  • S.SillankorvaR.OliveiraM.J.VieiraI.W.SutherlandJ.AzeredoBacteriophage F S1 infection of Pseudomonas fluorescens planktonic cells versus biofilmsBiofouling2032004133138
  • S.KumariK.HarjaiS.ChhibberEvidence to support the therapeutic potential of bacteriophage Kpn5 in burn wound infection caused by Klebsiella pneumoniae in BALB/c miceJ Microbiol Biotechnnol202010935941
  • B.R.LevinJ.J.BullPopulation and evolutionary dynamics of phage therapyNat Rev Microbiol22004166173
  • S.SillankorvaC.RodriguesH.OliveiraJ.AzeredoCombined antibiotic-phage therapies to control Pseudomonas aeruginosa biofilmsInstit Biotechnol Bioeng20124710
  • S.HagensA.HabelU.BlasiAugmentation of the antimicrobial efficacy of Antibiotics by Filamentous phageMicrob Drug Resist1232006164168
  • M.RellaD.HaasResistance of Pseudomonas aeruginosa PAO tonalidixic acid and low levels of b lactam antibiotics: mapping of chromosomal genesAntimicrob Agents Chemother221982242249
  • E.Bergogne-BerezinAntibacterial activity of ceftriaxoneRev Med Int61985178186
  • A.M.ComeauF.TetartS.N.TrojetM.F.Pre‘reH.M.KrischPhage antibiotic synergy (PAS): b-lactam and quinolone antibiotics stimulate virulent phage growthPLoS One282007e799
  • J.L.FothergillE.MowatM.J.WalshawM.J.LedsonC.E.JamesC.WinstanleyEffect of antibiotic treatment on bacteriophage production by a cystic fibrosis epidemic strain of Pseudomonas aeruginosaAntimicro Agents Chemotherapy5512011426428
  • Laura L.BowleraGeorge G.ZhanelT.Blake BallbLaura LSawardMature Pseudomonas aeruginosa biofilms prevail compared to young biofilms in the presence of ceftazidimeAntimicrobial Agents Chemotherapy569201249764979
  • J.B.KaplanAntibiotic-induced biofilm formationInt J Artif Organs3492011737751